Intrinsic value of Estrella Immunopharma, Inc. (ESLA)
Live fair value data for Estrella Immunopharma, Inc. (ESLA) is currently unavailable. Please check again shortly.
Current Price: $423.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Estrella Immunopharma, Inc. (ESLA) undervalued or overvalued?
Based on the current model output, Estrella Immunopharma, Inc. appears to be undervalued with a upside of 51.00%.
Fair value vs market price — Estrella Immunopharma, Inc. (ESLA)
Unlock premium access to view the live fair value comparison against current market price for ESLA.
Frequently Asked Questions - ESLA
How is ESLA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ESLA.
Is ESLA undervalued or overvalued right now?
ESLA is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ESLA: open their intrinsic value pages.